| UniProt ID | CR3L4_HUMAN | |
|---|---|---|
| UniProt AC | Q8TEY5 | |
| Protein Name | Cyclic AMP-responsive element-binding protein 3-like protein 4 | |
| Gene Name | CREB3L4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 395 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type II membrane protein. Golgi apparatus membrane Single-pass type II membrane protein . May also be located in Golgi apparatus. Processed cyclic AMP-responsive element-binding protein 3-like protein 4: |
|
| Protein Description | Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but not to CRE element. Preferentially binds DNA with to the consensus sequence 5'-T[GT]ACGT[GA][GT]-3' and has transcriptional activation activity from UPRE. Binds to NF-kappa-B site and has transcriptional activation activity from NF-kappa-B-containing regulatory elements (By similarity).. | |
| Protein Sequence | MDLGIPDLLDAWLEPPEDIFSTGSVLELGLHCPPPEVPVTRLQEQGLQGWKSGGDRGCGLQESEPEDFLKLFIDPNEVYCSEASPGSDSGISEDPCHPDSPPAPRATSSPMLYEVVYEAGALERMQGETGPNVGLISIQLDQWSPAFMVPDSCMVSELPFDAHAHILPRAGTVAPVPCTTLLPCQTLFLTDEEKRLLGQEGVSLPSHLPLTKAEERVLKKVRRKIRNKQSAQDSRRRKKEYIDGLESRVAACSAQNQELQKKVQELERHNISLVAQLRQLQTLIAQTSNKAAQTSTCVLILLFSLALIILPSFSPFQSRPEAGSEDYQPHGVTSRNILTHKDVTENLETQVVESRLREPPGAKDANGSTRTLLEKMGGKPRPSGRIRSVLHADEM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 51 | Ubiquitination | EQGLQGWKSGGDRGC HHCCCCHHCCCCCCC | 46.15 | 21906983 | |
| 63 | Phosphorylation | RGCGLQESEPEDFLK CCCCCCCCCCHHHHH | 45.55 | 27251275 | |
| 87 | Phosphorylation | CSEASPGSDSGISED ECCCCCCCCCCCCCC | 31.80 | 28348404 | |
| 100 | Phosphorylation | EDPCHPDSPPAPRAT CCCCCCCCCCCCCCC | 36.92 | 28348404 | |
| 107 | Phosphorylation | SPPAPRATSSPMLYE CCCCCCCCCCCCHHH | 30.89 | 27732954 | |
| 108 | Phosphorylation | PPAPRATSSPMLYEV CCCCCCCCCCCHHHH | 31.31 | 27732954 | |
| 109 | Phosphorylation | PAPRATSSPMLYEVV CCCCCCCCCCHHHHH | 15.24 | 27732954 | |
| 113 | Phosphorylation | ATSSPMLYEVVYEAG CCCCCCHHHHHHHHH | 10.63 | 27732954 | |
| 117 | Phosphorylation | PMLYEVVYEAGALER CCHHHHHHHHHHHHH | 12.77 | 21253578 | |
| 192 | Ubiquitination | QTLFLTDEEKRLLGQ EEEEECHHHHHHHCC | 61.25 | 29967540 | |
| 194 | Ubiquitination | LFLTDEEKRLLGQEG EEECHHHHHHHCCCC | 46.42 | - | |
| 203 | Phosphorylation | LLGQEGVSLPSHLPL HHCCCCCCCCCCCCC | 45.48 | 24719451 | |
| 212 | Ubiquitination | PSHLPLTKAEERVLK CCCCCCCHHHHHHHH | 62.58 | 29967540 | |
| 218 | Ubiquitination | TKAEERVLKKVRRKI CHHHHHHHHHHHHHH | 5.79 | 29967540 | |
| 219 | Ubiquitination | KAEERVLKKVRRKIR HHHHHHHHHHHHHHH | 46.49 | 29967540 | |
| 238 | Ubiquitination | AQDSRRRKKEYIDGL HHHHHHHHHHHHHHH | 48.41 | 29967540 | |
| 239 | Ubiquitination | QDSRRRKKEYIDGLE HHHHHHHHHHHHHHH | 54.67 | 29967540 | |
| 241 | Ubiquitination | SRRRKKEYIDGLESR HHHHHHHHHHHHHHH | 17.12 | 22505724 | |
| 261 | Ubiquitination | AQNQELQKKVQELER HHHHHHHHHHHHHHH | 68.48 | 22505724 | |
| 262 | Ubiquitination | QNQELQKKVQELERH HHHHHHHHHHHHHHC | 35.87 | - | |
| 339 | O-linked_Glycosylation | VTSRNILTHKDVTEN CCCCCCCCCHHHHHC | 24.07 | 55823753 | |
| 341 | Ubiquitination | SRNILTHKDVTENLE CCCCCCCHHHHHCHH | 48.97 | - | |
| 344 | O-linked_Glycosylation | ILTHKDVTENLETQV CCCCHHHHHCHHHHH | 29.32 | 55823759 | |
| 349 | O-linked_Glycosylation | DVTENLETQVVESRL HHHHCHHHHHHHHHH | 29.81 | 55823765 | |
| 354 | O-linked_Glycosylation | LETQVVESRLREPPG HHHHHHHHHHCCCCC | 25.63 | 55823769 | |
| 366 | N-linked_Glycosylation | PPGAKDANGSTRTLL CCCCCCCCCCHHHHH | 55.89 | UniProtKB CARBOHYD | |
| 368 | Phosphorylation | GAKDANGSTRTLLEK CCCCCCCCHHHHHHH | 17.96 | - | |
| 369 | Phosphorylation | AKDANGSTRTLLEKM CCCCCCCHHHHHHHC | 29.13 | - | |
| 375 | Acetylation | STRTLLEKMGGKPRP CHHHHHHHCCCCCCC | 42.70 | 7377613 | |
| 383 | Phosphorylation | MGGKPRPSGRIRSVL CCCCCCCCCCCCEEE | 41.82 | 24719451 | |
| 388 | Phosphorylation | RPSGRIRSVLHADEM CCCCCCCEEEECCCC | 27.02 | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CR3L4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CR3L4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CR3L4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CREM_HUMAN | CREM | physical | 16595651 | |
| LRC4C_HUMAN | LRRC4C | physical | 21988832 | |
| GANAB_HUMAN | GANAB | physical | 21988832 | |
| S19A3_HUMAN | SLC19A3 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...